Resources Contact Us Home
Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells

Image Number 2 for United States Patent #4861589.

The present invention provides a lymphocyte-mediated immunotherapy for the treatment of human or animal subjects afflicted with abnormal or tumor cells which express a MHC Class II antigen on their surface. The method utilizes inducer T-cell clones or lines having a demonstrable specificity for an identifiable antigen. These T-cells are activated in-vivo to express cytolytic and therapeutic activity against the abnormal or tumor cells in the subject.

  Recently Added Patents
Substituted thiophene pentamers
Adaptive known signal canceller
Sensor system
Method for the synthesis of an array of metal nanowire capable of supporting localized plasmon resonances and photonic device comprising said array
Device for data routing in networks
Nickel-cobalt-manganese multi-element lithium ion battery cathode material with dopants and its methods of preparation
Correcting color plate data for mis-registration in a sub-scanning direction by performing a pixel transition at the transition point aligned in the main-scanning direction
  Randomly Featured Patents
Ethoxyphenyl piperidines and uses thereof
Multi-rate wireless communications system
Scale deposition preventing agent
Method for delivering and positioning implants in the intervertebral disc environment
Armor-piercing projectile
Golf club with adjustable weight
Suspension assembly
Cellular, multi-layer material for forming a heat-insulating bag
Water-resistant mastic membrane
Alternating copolyamide prepared on a polymer matrix